Table 1.
Comparison of the clinical and epidemiologic characteristics between mite-sensitized rhinitis and asthma, and non-mite-sensitized healthy controls.
| Characteristics | Mite-sensitized | P-value | Mite-sensitized | Non-mite-sensitized | P-value | |
|---|---|---|---|---|---|---|
| Rhinitis (n = 20) | Asthma (n = 18) | Total (n = 38) | Controls (n = 22) | |||
| Age (yr) | 4.35 ± 0.40 | 4.39 ± 0.53 | 0.848 | 4.37 ± 0.45 | 4.59 ± 0.36 | 0.178 |
| Sex, male | 14 (70.0%) | 12 (66.7%) | 0.460 | 26 (68.4%) | 10 (45.5%) | 0.266 |
| Probiotic supplements | 6 (30.0%) | 10 (55.6%) | 0.370 | 16 (42.1%) | 8 (36.4%) | 1.000 |
| Cesarean delivery | 6 (30.0%) | 6 (33.3%) | 1.000 | 12 (31.6%) | 6 (27.3%) | 1.000 |
| Maternal atopy | 6 (30.0%) | 10 (55.6%) | 0.524 | 16 (42.1%) | 10 (45.5%) | 0.858 |
| Passive smoking | 8 (40.0%) | 10 (55.6%) | 0.740 | 18 (47.4%) | 12 (54.5%) | 0.705 |
| Household income | ||||||
| Low, 500,000 NTD | 10 (50.0%) | 9 (50.0%) | 0.276 | 19 (50.0%) | 10 (45.5%) | 0.152 |
| Medium, 500,000–1,000,000 NTD | 4 (20.0%) | 7 (38.9%) | 11 (28.9%) | 12 (54.5%) | ||
| High, > 1,000,000 NTD | 6 (30.0%) | 2 (11.1%) | 8 (21.1%) | 0 (0.0%) | ||
| Allergen-specific IgE, kU/L | ||||||
| D. pteronyssinus | 54.58 ± 42.63 | 20.8 ± 34.07 | 0.065 | 38.58 ± 41.53 | 3.27 ± 8.69 | 0.021 |
| D. farinae | 38.63 ± 38.21 | 12.49 ± 18.64 | 0.095 | 26.25 ± 32.62 | 1.41 ± 3.33 | 0.011 |
| Total serum IgE, kU/L | 623.20 ± 632.22 | 164.52 ± 192.84 | 0.043 | 405.93 ± 521.29 | 44.92 ± 36.31 | 0.008 |
| Total fecal IgE, kU/L | 25.20 ± 32.45 | 4.63 ± 3.94 | 0.182 | 15.46 ± 25.39 | 1.92 ± 1.26 | 0.003 |
All P-values < 0.05, which is in bold, are significant.
Data shown are mean ± SD or number (%) of patients as appropriate.
yr year, NTD New Taiwan Dollar, IgE immunoglobulin E.